Ghosh N, Manzoor BS, Fakhri B, Emechebe N, et al. Real-world comparative effectiveness of venetoclax-obinutuzumab versus Bruton tyrosine kinase inhibitors for frontline chronic lymphocytic leukaemia. Br J Haematol 2024;205:1395-1403.
PMID: 39049159